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Control of Regulatory T Cell
Development by the
Transcription Factor Foxp3
Shohei Hori,1 Takashi Nomura,2 Shimon Sakaguchi1,2*
Regulatory T cells engage in the maintenance of immunological self-tolerance
by actively suppressing self-reactive lymphocytes. Little is known, however,
about the molecular mechanism of their development. Here we show that
Foxp3, which encodes a transcription factor that is genetically defective in an
autoimmune and inﬂammatory syndrome in humans and mice, is speciﬁcally
expressed in naturally arising CD4 regulatory T cells. Furthermore, retroviral
gene transfer of Foxp3 converts naı ¨ve T cells toward a regulatory T cell phe-
notype similar to that of naturally occurring CD4 regulatory T cells. Thus,
Foxp3 is a key regulatory gene for the development of regulatory T cells.
To maintain immunological unresponsive-
ness to self-constituents (i.e., self-tolerance),
potentially hazardous self-reactive lympho-
cytes are eliminated or inactivated during
their development (1). Activation and expan-
sion of self-reactive T lymphocytes that have
escaped thymic clonal deletion is actively
suppressed in the periphery by naturally oc-
curring CD4 regulatory T cells (TR), the
majority of which constitutively express
CD25 [interleukin (IL)-2 receptor -chain]
(2–6). CD25CD4 TR cells are at least in
part produced by the thymus as a functionally
mature T cell subpopulation (7, 8), and their
reduction or functional alteration in rodents
leads to the spontaneous development of var-
ious organ-specific autoimmune diseases in-
cluding autoimmune thyroiditis, gastritis, and
type 1 diabetes (6–9). TR cells also appear to
maintain a balanced response to environmen-
tal antigens, preventing inflammatory bowel
disease (IBD) and allergy in rodents (10, 11).
Several studies have provided findings
that offer clues to the potential pathway by
which TR cells develop. Similar multiorgan
autoimmune diseases, allergy, and IBD de-
velop in the X-linked recessive disease, IPEX
(immune dysregulation, polyendocrinopathy,
enteropathy, X-linked syndrome) or XLAAD
(X-linked autoimmunity-allergic dysregula-
tion syndrome) (12). A mouse mutant strain,
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Fig. 1. Expression of Foxp3 in a subpopulation of CD4 T
cells in the thymus and periphery. (A) BALB/c thymocytes
were sorted into CD4–CD8– (DN), CD4CD8 (DP), CD4–
8 (CD8) or CD48– (CD4) cells (left). CD48– thymo-
cytes were further separated into CD25 or CD25– cells
(right). cDNA from each population was subjected to non-
saturating PCR using Foxp3- or HPRT (hypoxanthine-
guanine phosphoribosyl-transferase)–speciﬁc primers (21).
(B) Pooled lymph node and spleen cells from BALB/c mice
were sorted into the indicated compartments, and nonsat-
urating RT-PCR analyses were carried out. CD4 cells were
further separated into CD25 or CD25– cells. (C) Quanti-
ﬁcation of relative Foxp3 mRNA levels in indicated CD4 T
cell subsets. cDNA samples were subjected to real-time
quantitative PCR analyses using primers and an internal
ﬂuorescent probe speciﬁc for Foxp3 or HPRT. The relative
quantity of Foxp3 in each sample was normalized to the
relative quantity of HPRT (21). (D) CD25–CD4 (open
symbols) or CD25CD4 cells (closed symbols) were ac-
tivated for indicated hours with plate-bound CD3 mAb in
the presence of IL-2 (circles) or CD28 mAb (squares) and
assessed for the expression of Foxp3 by real-time quanti-
tative RT-PCR. (A) to (D) each show one representative
result of three independent experiments.
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recessive autoimmune and inflammatory dis-
eases as a result of uncontrolled activation
and expansion of CD4 T cells (13–16).
Recent efforts to identify the genetic defect in
IPEX/XLAAD patients or scurfy mice have
revealed mutations in a common gene,
Foxp3, which encodes a forkhead-winged–
helix transcription factor designated Scurfin
(17–20). Immunological similarities between
the autoimmunity and inflammation pro-
duced by manipulating CD25CD4 TR
cells and those induced by genetic defects in
Foxp3 prompted us to investigate the possible
contribution of Foxp3 to the development or
function of regulatory T cells.
We first examined the expression of Foxp3
mRNA in the thymus and the periphery of
normal mice by reverse transcriptase–polymer-
ase chain reaction (RT-PCR) (21). In the thy-
mus, CD25CD4CD8– thymocytes, which
constitute 5% of CD4CD8– thymocytes (7),
predominantly transcribed Foxp3, whereas
CD4–CD8 and other immature thymocyte
populations did not (Fig. 1A). In the periphery,
CD4 T cells specifically transcribed the gene,
whereas CD8 T cells and CD19 B cells did
not (Fig. 1B) (17). Among CD4 T cells, the
CD25 subset, which constitutes 5 to 10% of
CD4 T cells in normal naı ¨ve mice, exhibited
predominant transcription. Real-time quantita-
tive PCR analyses revealed that the Foxp3
mRNA level in CD25CD4 cells was 100-
fold more abundant than in CD25–CD4 cells
(Fig. 1C). A low level of expression in CD25–
CD4 cells was confined to the CD45RBlow
population, which has been previously reported
to contain regulatory activity (22, 23). These
results indicate that Foxp3 expression is pre-
dominantly restricted to the CD25CD4 pop-
ulation in both the thymus and periphery.
Expression of Foxp3 is not a mere conse-
quence of T cell activation, because in vitro
stimulation of CD25–CD4 cells for 3 days
by monoclonal antibodies (mAbs) to CD3 in
the presence of IL-2 or CD28 mAb failed to
elicit Foxp3 expression (Fig. 1D). Neither
effector Th1 nor effector Th2 cells prepared
from naı ¨ve T cells expressed Foxp3 (fig. S1).
Furthermore, stimulation of CD25CD4
cells with CD3 mAb and IL-2 did not alter
their expression levels of Foxp3. Thus, Foxp3
expression is stable in CD25CD4 TR cells
irrespective of the mode or state of activation.
We next determined whether forced ex-
pression of Foxp3 in naı ¨ve T cells could
convert these cells toward a regulatory T cell
phenotype. Bicistronic retroviral vectors ex-
pressing Foxp3 and green fluorescent protein
(GFP) (Foxp3/MIGR1) or GFP alone
(MIGR1) were generated (Fig. 2A). Periph-
eral CD25–CD4 cells from normal naı ¨ve
mice were stimulated with CD3 mAb and
IL-2 and infected with either retrovirus. One
week after infection, the proliferative re-
Fig. 2. Retroviral transduction of Foxp3 into naı ¨ve CD4 T cells. (A) Foxp3 cDNA was inserted
into the MIGR1 retrovirus vector (21). This vector simultaneously expresses two cDNAs, Foxp3
and GFP, with the use of an internal ribosomal entry site (IRES). (B) CD3 mAb–stimulated
proliferative response of freshly isolated CD25–CD4 cells and GFP Foxp3/MIGR1- or
MIGR1-infected CD25–CD4 cells. [3H] thymidine incorporation was measured as an indicator
of cell proliferation and expressed as the mean ( SD) of triplicate cultures. cpm, counts per
minute. (C) IL-2, IFN-, IL-4, or IL-10 concentration in the culture supernatant of CD3
mAb–stimulated culture of GFP Foxp3/MIGR1- or MIGR1-infected CD25–CD4 cells (mean 
SD). (D) Foxp3/MIGR1- or MIGR1-infected T cells derived from CD25–CD4 cells were stained
with phycoerythrin (PE)–labeled mAb for CD25, GITR, CD103, CD4, CD44, or an irrelevant
antigen (control), along with detection of GFP. Intracellular CTLA-4 molecules were detected
with PE-labeled CTLA-4 or isotype-matched control mAb (21). (B) to (D) each show one
representative result of three independent experiments.
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(TCR) stimulation, cytokine production, and
expression of cell surface molecules were
examined. Retroviral transduction led to ex-
pression of GFP in 30 to 60% of CD4 cells.
Upon TCR stimulation with CD3 mAb,
GFP cells from Foxp3/MIGR1-infected cul-
tures proliferated poorly in contrast to the
vigorous proliferation of GFP cells from
control MIGR1-infected cells or freshly pre-
pared CD25–CD4 cells (Fig. 2B). In addi-
tion, Foxp3/MIGR1-infected GFP cells pro-
duced very little but detectable IL-2, IFN-,
IL-4, and IL-10 as compared to GFP
MIGR1-infected cells, which secreted large
amounts of these cytokines (Fig. 2C). Al-
though these Foxp3-expressing cells pro-
duced higher amounts of cytokines than
freshly isolated CD25CD4 cells (fig. S2),
cytokine-producing cells were largely con-
fined to cells expressing low levels of GFP
(and hence Foxp3).
Naturally arising CD25CD4 TR cells
characteristically express CD25, cytotoxic T
lymphocyte-associated antigen–4 (CTLA-4),
glucocorticoid-induced tumor necrosis factor
receptor family–related gene (GITR), and
CD103 (E integrin) (6–10, 24–28). Al-
though the activation of CD25–CD4 cells
for retroviral infection led to expression of
these molecules in both Foxp3/MIGR1- and
MIGR1-infected cells, GFP cells in the
former expressed CD25, GITR, and CTLA-4
at higher levels than GFP– cells or GFP
MIGR1-infected cells (Fig. 2D, table S1).
Among the GFP Foxp3-transduced cells,
the higher the level of GFP (Foxp3) expres-
sion, the higher the expression was of these
molecules (Fig. 2D). Furthermore, only
GFPhigh (Foxp3high) cells in the Foxp3/
MIGR1-infected cells expressed CD103,
with no expression on MIGR1-infected cells.
Because Foxp3 transduction did not affect the
expression levels of either CD4 or CD44, the
Foxp3-induced high expression of these TR-
associated molecules is most likely due to
specific genetic instruction and not simply
excessive cell activation by Foxp3. From
these experiments, we conclude that trans-
duction of Foxp3 could render naı ¨ve T cells
hyporesponsive to TCR stimulation, inhibit
cytokine production, and up-regulate expres-
sion of cell surface molecules closely associ-
ated with the regulatory function of naturally
occurring CD25CD4 TR cells (29, 30).
We next assessed the potential of Foxp3-
transduced T cells to show suppressive activity.
Foxp3/MIGR1-infected CD25–CD4 T cells
could specifically reduce proliferation of fresh-
ly prepared CD25–CD4 responder T cells
when stimulated with CD3 mAb (Fig. 3A).
This suppression was associated with the inhi-
bition of IL-2 production of the responder pop-
ulation in a fashion similar to that of natural
CD25CD4 TR cells (Fig. 3B) and correlated
with the level of GFP (Foxp3) expression in the
infected population [Supporting Online Ma-
terial (SOM) Text, fig. S3A]. These GFPhigh
cells also suppressed IL-4 secretion by
CD25–CD4 responder T cells (fig.
S3B). CD25CD4 cells, whether infected
with Foxp3/MIGR1 or MIGR1, showed
equally potent suppressive activity (Fig. 3A).
To examine whether antigen-specific na-
ı ¨ve T cells could be converted to regulatory T
cells by ectopic Foxp3 expression, we used
recombination-activating gene (RAG)–defi-
cient DO11.10 CD4 T cells, which express
ovalbumin (OVA) peptide–specific trans-
0.00
0.25
0.50
0.75
PBS αααα IL-10R αααα TGF-ββββ αααα IL-10R
+αααα TGF-ββββ
A CD25+CD4+
0.0
0.1
0.2
0.3
0.4 CD25-CD4+
c
p
m
 
(
x
1
0
-
5
)
0.0
0.1
0.2
0.3
0.4
1.0
0.0 0.5 1.0 1.5 2.0 2.5
No. of GFP+ cells (x10-4)
B
+MIGR1
IL-2
+ Foxp3/MIGR1
p
g
/
m
l
CD25 -  alone
0
50
100
150
+CD25 +
D
0.0
0.3
0.6
0.9
1.2
1.5
0.0 0.5 1.0 1.5 2.0 2.5
OVA peptide
0.0
0.3
0.6
0.9
1.2
1.5
0.0 0.5 1.0 1.5 2.0 2.5
anti-CD3
No. of GFP+ cells (x10-4)
c
p
m
 
(
x
1
0
-
5
)
C
E
0
0.5
1.0
1.5
CD25 -  alone
+Foxp3/MIGR1
c
p
m
 
(
x
1
0
-
5
)
+Foxp3/MIGR1
(transwell)
c
p
m
 
(
x
1
0
-
5
)
DO.RAG-
0.0
0.1
0.2
1.0
1.4
0.6
0.0 0.5 1.0 1.5 2.0
No. of GFP+ cells (x10-4)
0.5 1.0 1.5 2.0 2.5 0.0
Fig. 3. Suppressive activity of Foxp3-transduced naı ¨ve CD4 T cells. (A) Graded doses of GFP cells
infected with either Foxp3/MIGR1 (closed circles) or MIGR1 (open circles) derived from BALB/c
CD25–CD4 (left) or CD25CD4 cells (right) were cultured with 2.5  104 freshly prepared
CD25–CD4 cells for 72 hours with CD3 mAb and 5.0  104 antigen-presenting cells (APCs).
Proliferation of cells was assessed as in Fig. 2B. Freshly isolated CD25CD4 cells were also
included in the assay (open squares). (B) Freshly prepared CD25–CD4 cells alone or mixed with
the same number of GFP Foxp3/MIGR1-(Foxp3/MIGR1) or MIGR1-infected CD25–CD4 cells
(MIGR1) or freshly isolated CD25CD4 cells (CD25) were stimulated with CD3 mAb, and
IL-2 concentration in the culture supernatant was measured as in Fig. 2C. (C) GFP cells from
DO11.10/RAG-2–/– CD4 cells infected with Foxp3/MIGR1 (closed circles) or MIGR1 (open circles)
were cultured with 2.0  104 freshly prepared DO11.10 CD4 cells in the presence of OVA peptide
and 4.0  104 APCs. (D) BALB/c CD25–CD4 cells were transduced with Foxp3 (closed circles) or
GFP alone (open circles) and sorted for GFP. Indicated numbers of GFP cells were mixed with
2.5  104 DO11.10 TCR transgenic CD4 cells and stimulated with either speciﬁc OVA peptide
(left) or CD3 mAb (right). (E) GFP Foxp3/MIGR1-infected T cells derived from BALB/c CD25–CD4
cells and an equal number of freshly prepared CD25–CD4 cells were separated or nonseparated
by a semipermeable membrane and stimulated with CD3 mAb and APCs on each side (left). IL-10
receptor (IL-10R) mAb, TGF- mAb, or the mixture of these two was added to the culture of freshly
prepared CD25–CD4 cells either alone (white bars) or in the presence of GFP Foxp3/MIGR1-
infected CD25–CD4 cells (gray bars) or freshly prepared CD25CD4 cells (black bars) (right)
(21). (A) to (E) each show one representative result of three independent experiments.
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CD25CD4 TR cells (7), and scarcely ex-
press Foxp3 (SOM Text, fig. S4). In the
absence of specific antigen, almost all T cells
from these animals remain in a naı ¨ve state.
Transgenic CD4 T cells infected with
Foxp3/MIGR1 suppressed the proliferation
of freshly prepared noninfected transgenic T
cells upon stimulation with specific OVA
peptides, whereas those infected with MIGR1
did not (Fig. 3C). These results collectively
indicate that ectopic expression of Foxp3 was
sufficient to convert otherwise nonregulatory
naı ¨ve T cells toward a regulatory T cell phe-
notype capable of suppressing proliferation
of other T cells, presumably through inhibi-
tion of IL-2 production (SOM Text, fig. S5).
Foxp3-transduced CD4 T cells appeared
to exert the suppressive activity in a similar
manner to that of naturally occurring
CD25CD4 TR cells (SOM Text, fig. S6).
First, Foxp3-transduced cells derived from
BALB/c CD25–CD4 cells failed to suppress
the proliferative response of DO11.10 TCR
transgenic CD4 T cells when stimulated with
OVA peptide, whereas polyclonal stimulation
with CD3 mAb induced suppression (Fig. 3D).
This indicates that Foxp3-transduced T cells
require stimulation through TCRs to exert sup-
pression (29, 30). Second, Foxp3-infected T
cells failed to suppress other T cells when sep-
arated by a semipermeable membrane, in con-
trast to effective suppression that was observed
when cell-cell contact was allowed (Fig. 3E).
These separated Foxp3-infected T cells even
enhanced T cell responses across the mem-
brane, presumably via cytokines they pro-
duced (fig. S2). In addition, neutralization of
transforming growth factor– (TGF-)o r
blocking of IL-10 receptor, either alone or in
combination, failed to abrogate suppression,
as was the case with natural CD25CD4 TR
cells. These results indicate that in vitro sup-
pression by Foxp3-transduced T cells may
not be mediated by humoral factors but re-
quires cell contact (29, 30).
Finally, we examined whether Foxp3/
MIGR1-infected T cells could suppress in vivo
the inflammation and the autoimmune disease
that have been shown to develop in the absence
of T cell regulation. For this, we used a model
of IBD and autoimmune gastritis that can be
induced in severe combined immuno-
deficiency (SCID) mice by the transfer of
CD25–CD45RBhighCD4 T cells from normal
BALB/c mice and prevented by cotransfer of
CD25CD4 TR cells (10, 31) (Fig. 4). CD25–
CD45RBhighCD4 cells from BALB/c mice
were infected with Foxp3/MIGR1 or MIGR1,
and GFP cells were cotransferred with freshly
prepared CD25–CD45RBhighCD4 cells. The
GFP Foxp3-transduced cells inhibited weight
loss, diarrhea, and histological development of
colitis and gastritis induced by the transfer of
CD25–CD45RBhighCD4 cells as effectively
as naturally occurring CD25CD4 cells. By
contrast, the cells transduced with GFP
alone failed to prevent disease, and rather
enhanced weight loss and the development
of colitis. Thus, transduction of Foxp3 can
render naı ¨ve T cells capable of preventing
autoimmune gastritis and IBD caused by
dysregulated immune responses toward
gastric self-antigens and commensal bacte-
ria, respectively (SOM Text).
The present study shows that Foxp3 is pre-
dominantly expressed in the CD25CD4 TR
population naturally arising in the thymus and
periphery and that Foxp3 expression in naı ¨ve T
cells can convert these cells to a regulatory T
cell phenotype functionally similar to naturally
occurring CD25CD4 TR cells. This result
suggests that Foxp3 may be a master regulatory
gene for cell-lineage commitment or develop-
mental differentiation of regulatory T cells in
the thymus and the periphery. Our results also
indicate that, in defining the naturally occurring
CD4 regulatory T cells engaged in preventing
autoimmune disease and immunopathology,
Foxp3 represents a more specific marker than
currently used cell-surface molecules (such as
CD25, CD45RB, CTLA-4, and GITR), which
are unable to completely discriminate between
regulatory T cells and activated, effector, or
memory T cells.
Mutations in the Foxp3 gene culminate in
the development of a fatal lymphoprolifera-
tive disorder associated with multiorgan pa-
thology both in mice and humans (12–20).
FOXP3 is predominantly expressed in human
CD25CD4 T cells as well (32). Further-
more, transduction of a mutant Foxp3 lacking
the forkhead domain, similar to the mutated
Foxp3 in scurfy mice (17), failed to confer
suppressive activity to CD25–CD4 T cells
(fig. S7). The present results therefore sug-
gest that mutations of the Foxp3 gene may
cause these disorders through develop-
mental or functional abnormality of the
CD25CD4 TR population.
Potentially, generation of TR cells by Foxp3
transduction of naı ¨ve T cells may provide a
previously unstudied therapeutic mode for
treatment of autoimmune and inflammatory
diseases and in transplantation tolerance.
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Fig. 4. Prevention of IBD and autoimmune gastritis by Foxp3-transduced T cells. (A) C.B-17 scid
mice received 4  105 fresh CD25–CD45RBhighCD4 cells either alone (n  6, where n is the
number of mice) (open squares) or together with 1.2  106 GFP sorted cells derived from
CD25–CD45RBhighCD4 cells infected with Foxp3/MIGR1 (n  7) (closed circles) or MIGR1 (n  5)
(open circles). Body weight is represented as the percentage of initial weight (mean  SD).
Astericks indicate signiﬁcant difference, P 	 0.01, Foxp3/MIGR1 versus other two groups by
Mann-Whitney test. (B) Histopathology of the colon and stomach in each group and in an
unreconstituted SCID mouse (None). (C) Colitis (left) and gastritis (right) were histologically
scored. Two mice in the group cotransferred with MIGR1-infected cells and one transferred with
CD25–CD45RBhighCD4 cells alone died of debilitation before histological examination. Results
shown in (A) to (C) are from a total of three independent experiments.
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Rewiring MAP Kinase Pathways
Using Alternative Scaffold
Assembly Mechanisms
Sang-Hyun Park, Ali Zarrinpar, Wendell A. Lim*
How scaffold proteins control information ﬂow in signaling pathways is poorly
understood: Do they simply tether components, or do they precisely orient and
activate them? We found that the yeast mitogen-activated protein (MAP) kinase
scaffold Ste5 is tolerant to major stereochemical perturbations; heterologous pro-
teininteractionscouldfunctionallyreplacenativekinaserecruitmentinteractions,
indicating that simple tethering is largely sufﬁcient for scaffold-mediated sig-
naling. Moreover, by engineering a scaffold that tethers a unique kinase set, we
could create a synthetic MAP kinase pathway with non-natural input-output
properties. These ﬁndings demonstrate that scaffolds are highly ﬂexible orga-
nizing factors that can facilitate pathway evolution and engineering.
Scaffold proteins are known to play a critical
role in a growing number of signaling path-
ways, including several mitogen-activated pro-
tein kinase (MAPK) cascades (1–4). In the
budding yeast Saccharomyces cerevisiae, the
scaffold proteins Ste5 and Pbs2 are essential for
the mating and high–osmolarity response
MAPK pathways, respectively (5–8). These
scaffold proteins contain binding sites for each
of the pathway kinases, as well as for upstream
signaling input proteins (Fig. 1).
Despite their importance, little is known
about the mechanism by which scaffold pro-
teins such as Ste5 contribute to efficient and
specific signaling (9). One model is that scaf-
fold proteins simply tether pathway compo-
nents, increasing their likelihood of acting on
one another. However, one might expect a
simple tethering scaffold to enhance but not
be required for signaling. Thus, because Ste5
is essential for signaling, and because of ev-
idence supporting conformational changes in-
duced by scaffold-kinase association (10, 11),
an alternative model is that Ste5 plays a more
complex catalytic role, precisely orienting
and/or allosterically regulating pathway ki-
nases (4). One way to distinguish between
these models would be to probe pathway
sensitivity to perturbations in assembly
mechanisms. If pathway function depended
on precise catalytic participation of the scaf-
fold, then strict stereochemical requirements
for kinase recruitment would be expected.
We therefore tested whether non-native
protein-protein interactions could be used to
build a scaffolded assembly capable of me-
diating proper mating pathway connectivity
and function. We took advantage of several
known mutations in Ste5 that selectively de-
stroy recruitment of the MAPK kinase kinase
(MAPKKK) Ste11 and the MAPK kinase
(MAPKK) Ste7. These mutations, respective-
ly termed Ste5* and Ste5**, each resulted in
a nonfunctional mating pathway (12). Defec-
tive recruitment interactions were then re-
placed with a heterologous protein-protein
interaction (Fig. 2A): the well-characterized
heterodimerization interaction between PDZ
domains from the mammalian proteins neu-
ronal nitric oxide synthase (nNOS) and syn-
trophin (13, 14). PDZ domains are interaction
modules involved in assembly of diverse sig-
naling complexes in higher eukaryotes (15,
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Fig. 1. Yeast mating and high-osmolarity MAPK
pathways require scaffold proteins Ste5 and
Pbs2. Both pathways require the shared MAP-
KKK Ste11 but exhibit no cross-signaling under
normal conditions. Ste5 has distinct docking
sites for Ste11, the MAPKK Ste7, and the MAPK
Fus3 (or the partially redundant MAPK Kss1,
not shown for simplicity) (5–7). Input to Ste5
occurs through a docking site for Ste4, the G
subunit of the heterotrimeric guanine nucleo-
tide–binding protein activated upon phero-
mone binding to the -factor receptor, Ste2.
Pbs2 functions as both the scaffold and MAPKK
of the osmolarity pathway: It has a MAPKK
domain, and it has been shown to bind Ste11
and the MAPK Hog1 (precise binding sites have
not been identiﬁed) (8). Pbs2 also binds the Src
homology 3 (SH3) domain from the upstream
osmosensor Sho1 through a proline-rich dock-
ing site (residues 94 to 100), indicated by PxxP
(26). A second branch of the osmoresponse
pathway involving the two-component sensor
protein Sln1 has been omitted for simplicity
(27). This branch of the pathway does not
require Sho1 or Ste11. All of the studies de-
scribed here were performed with strains lack-
ing this pathway branch (ssk2
 and ssk22
).
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